Previous 10 | Next 10 |
2023-07-31 13:14:31 ET Summary Baillie Gifford's 13F portfolio value increased from ~$111B to ~$118B this quarter. The top three holdings are MercadoLibre, NVIDIA, and Tesla Motors, which make up ~17% of the portfolio. Baillie Gifford made stake increases in MercadoLibre, PDD ...
2023-07-30 07:10:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Small Cap Fund had a strong performance in Q2 2023, up 6.49% and up 16.54% for t...
2023-07-30 06:20:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Opportunity Fund outperformed the broader market in Q2 2023, with a 16.31% retur...
2023-07-28 01:00:57 ET Image source: The Motley Fool. DexCom (NASDAQ: DXCM) Q2 2023 Earnings Call Jul 27, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: DexCom (DXCM) Q2 2023 Earnings Call Transcript
2023-07-27 20:14:09 ET Dexcom, Inc. (DXCM) Q2 2023 Earnings Conference Call July 27, 2023 04:30 PM ET Company Participants Sean Christensen - Director, Corporate Affairs & Head of IR Kevin Sayer - Executive Chairman, CEO & President Jereme Sylvain - EVP, ...
2023-07-27 16:05:49 ET DexCom press release ( NASDAQ: DXCM ): Q2 Non-GAAP EPS of $0.34 beats by $0.11 . Revenue of $871.3M (+25.2% Y/Y) beats by $30.35M . U.S. revenue growth of 21% and international revenue growth of 38% on a reported basis. International...
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2023. Second Quarter 2023 Financial Highlights: Revenue grew 25% versus the same quarter of the prior year to $871.3 million on a reported basis and 26% on an organic 1 ba...
2023-07-23 21:25:42 ET Summary Actually the "bad news" is really good news as well, since they are affording a fantastic opportunity to buy on the cheap. How can we be having a new bull market when the best names could be falling? The rally is widening, other sectors are growing a...
2023-07-09 12:00:00 ET Despite a disappointing start to 2023, the healthcare sector has several promising industries waiting to outperform this year, Goldman Sachs said in a recent report after the bank concluded its annual healthcare conference in Dana Point, California, last month. Th...
2023-07-06 13:03:01 ET Summary DexCom's share price has increased by 414% over the last five years, driven by the company's innovative continuous glucose monitoring systems. Despite a high price-to-earnings ratio, the company has recently revised its 2025 growth targets upwards by...
News, Short Squeeze, Breakout and More Instantly...
2024-07-04 10:00:00 ET Growth-oriented investors have experienced a bit of a roller-coaster ride over the past few years. Many companies in the "growth stock" category were struggling just two years ago, but in the bull market we are now experiencing, they're delivering very different resul...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the...